Mandate

Vinge advises Lantmännen in connection with its acquisition of the Vaasan Group

January 15, 2015

Vinge advises Lantmännen Ek För (”Lantmännen”) in connection with its acquisition of the Vaasan Group (”Vaasan”) from Lion Capital. In 2013, Vaasan had net sales of approx. MEUR 415 and in total approx. 2,745 employees. Vaasan is engaged in the baking industry in the Nordic and Baltic regions and is a worldwide supplier of thin crisp and crisp bread. The purchase price is confidential. The transaction is conditional upon approval by the relevant competition authorities.

Vinge’s team consists of responsible partner Christina Kokko, partner Jonas Johansson and associates Sofie Bjärtun and Alex Miler. Associate Malin Malm has advised on IP matters, Matilda Gustafsson and Johan Cederblad have advised on environmental and real property matters, Anders Morén has advised on financing matters and Sara Strandberg has advised on employment law. Partner Marcus Glader and associates Grant McKelvey, Emil Fahlén Godö, Johan Wahlbom and Victoria Grossmann are advising on the competition law aspects of the transaction.

Vinge has also coordinated the work performed by Castrén & Snellman (Finland), Lawin (Estonia, Latvia and Lithuania), Haavind (Norway), Bech-Bruun (Denmark) and Heuking Kühn Lüer Wojtek (Germany).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025